Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.

Sieta T de Vries Petra Denig Adriana AndrićMarina Dimov Di GiustiAlicia Ptaszynska-NeophytouLinda Härmark Peter G M Molnull null

Published in: Drug safety (2021)

HCPs' and patients' motives to report or not to report ADRs to the national agency were mostly similar across the three countries. Such motives can be used in general strategies to promote and increase ADR reporting. The observed differences provide guidance to further fine-tune ADR reporting at a national level.

Keyphrases

adverse drug
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
quality improvement
prognostic factors
peritoneal dialysis
emergency department
electronic health record